Orders from 100 GBP Free delivery from 205 GBP Ready for pickup dead drop: collect in 5 min

Bromazolam. CAS number: 71368-80-4. Molecular formula: C17H13BrN4. Molecular weight: 353.2 g/mol. Chemical parameters are listed in the product properties table.

Chemical name
8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
Other names
XLI-269, 8-Bromo-alprazolam
CAS number
71368-80-4
Molecular formula
C17H13BrN4
Molecular weight
353.2 g/mol
Chemical form
Physical appearance
Country of origin
Condition
New

4.00 GBP

Portion

4.00 GBP / 1 mg 4.00 GBP

Pack: 1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 0.1 g, 0.2 g

  • External lab verification (≥98%) and full CAS properties sheet on the product card.
  • Discreet unbranded parcel (locker / courier) or ready dead-drop pickup in your city.
  • No mandatory registration required (BTC / XMR) · 24/7 live chat (14:00–22:00 chemist shift).

Reference information

Bromazolam belongs to the “Benzodiazepines and thienodiazepines” category. Chemical name (IUPAC): 8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine. CAS number: 71368-80-4. Molecular formula: C17H13BrN4. Molecular weight: 353.2 g/mol.

Supplied form: tablets, each pill 1 mg (1 pill = 1 mg; e.g. 10 mg portion = 10 pills of 1 mg). Available portion sizes listed in RC Drugs UK: 0.001 g, 0.005 g, 0.01 g, 0.025 g, 0.05 g, 0.1 g, 0.2 g. Orders ship via courier, parcel locker, or ready dead-drop pickup points on the map. Payment in Bitcoin (BTC) and Monero (XMR). Benzodiazepines and thienodiazepines: Clonazolam, Etizolam, Flualprazolam. Analytical reference material strictly for laboratory research; not for human consumption. Verified identity and physicochemical parameters are shown in the product properties table.

Verified Neurochemical & Toxicological Intelligence

Bromazolam

GABA-A Positive Allosteric Modulator (8-Bromo-alprazolam) Triazolobenzodiazepine
Verified PubChem & CAS Identity C17H13BrN4 · CAS 71368-80-4 · CID 12562546
Calibrated Physical Form Precision Tablets · 1 Tablet = 1 mg
≥98% Analytical Purity Verified 353.2 g/mol
Peer-Reviewed & Agency Citations 2 · verified sources

Receptor Telemetry & Mechanism of Action

GABAₐ α₂/α₃ Anxiolysis & Myorelaxation High PAM
GABAₐ α₁ Hypnotic / Sedative Drive Moderate-High
GABAₐ α₅ Amnestic / Cognitive Modulation Moderate

Non-selective high-affinity PAM across alpha1, alpha2, alpha3, and alpha5 GABA-A receptor subtypes (structurally the 8-bromo analogue of alprazolam).

Biotransformation & Active Metabolites

Hepatic CYP3A4 hydroxylation to alpha-hydroxybromazolam and 4-hydroxybromazolam followed by glucuronidation.

Temporal Pharmacokinetics

GABA-A Positive Allosteric Modulator (8-Bromo-alprazolam) — 1 tablet = 1 mg sits at the light-to-common threshold; compared to Etizolam, Bromazolam is heavier on physical muscle relaxation and sedation and lasts 2–3 hours longer, while remaining significantly more forgiving per mg than Flualprazolam or Clonazolam.

  1. Onset 20–45 min
  2. Peak Window 1.5–3 h
  3. Total Window 6–10 h
  4. Residual / Half-Life 8–18 h residual sedation

1 tablet = 1 mg sits at the light-to-common threshold; compared to Etizolam, Bromazolam is heavier on physical muscle relaxation and sedation and lasts 2–3 hours longer, while remaining significantly more forgiving per mg than Flualprazolam or Clonazolam.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
0.5 mg
Cognitive & Sensory

Subtle threshold receptor activity (GABA-A Positive Allosteric Modulator (8-Bromo-alprazolam)).

Somatic & Autonomic

Minimal baseline autonomic shift.

Light
0.5–1 mg
Cognitive & Sensory

Mild, clear-headed expression of primary class profile.

Somatic & Autonomic

Light somatic modulation.

Common Reference
1–2 mg
Cognitive & Sensory

Full characteristic neurochemical and perceptual profile documented in literature.

Somatic & Autonomic

Moderate somatic relaxation, ataxia, or autonomic tone depending on class.

Strong
2–4 mg
Cognitive & Sensory

Pronounced intensity, cognitive/motor impairment, or deep immersion.

Somatic & Autonomic

Marked somatic load and heightened adverse-event sensitivity.

Heavy / Toxic Zone
4–5+ mg
Cognitive & Sensory

Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.

Somatic & Autonomic

High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

Opioids (O-DSMT, tramadol, morphine, oxycodone, fentanyl)

Synergistic brainstem respiratory depression causing unconsciousness and fatal respiratory arrest.

Alcohol, GHB/GBL, and Barbiturates

Extreme CNS depression, complete anterograde amnesia, loss of airway reflexes, and fatal aspiration.

Elevated Hazard — Avoid

Dissociatives (Ketamine, 2-FDCK, DCK, O-PCE, MXE)

Unpredictable sedation, severe motor ataxia, blackout, and emesis aspiration hazard.

Caution / Receptor Attenuation

CYP3A4 inhibitors (grapefruit juice, ketoconazole) & Stimulants

CYP3A4 inhibitors prolong plasma half-life; stimulants mask sedation until they wear off.

Structural Isomer & Sibling Comparison

1 tablet = 1 mg sits at the light-to-common threshold; compared to Etizolam, Bromazolam is heavier on physical muscle relaxation and sedation and lasts 2–3 hours longer, while remaining significantly more forgiving per mg than Flualprazolam or Clonazolam.

Physicochemical Stability & Storage

Form: Precision-pressed 1 mg analytical tablets (1 tablet = 1 mg). · Parent molecule soluble in ethanol, propylene glycol, and DMSO; sparingly soluble in water.

Store sealed in a cool, dry, light-protected container away from humidity.

Cross-Tolerance & Dependence Profile

Complete cross-tolerance across all GABA-A benzodiazepines/thienodiazepines. Rapid physical dependence develops with continuous daily exposure; abrupt cessation after prolonged intake can trigger life-threatening rebound seizures and delirium.

Comprehensive Analytical & Toxicological Monograph

Bromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine; CAS 71368-80-4, PubChem CID 12562546) is a triazolobenzodiazepine reference compound (C17H13BrN4, 353.2 g/mol) classified pharmacologically as a GABA-A Positive Allosteric Modulator (8-Bromo-alprazolam). Non-selective high-affinity PAM across alpha1, alpha2, alpha3, and alpha5 GABA-A receptor subtypes (structurally the 8-bromo analogue of alprazolam). Hepatic CYP3A4 hydroxylation to alpha-hydroxybromazolam and 4-hydroxybromazolam followed by glucuronidation. In published observational and toxicological literature, threshold response is noted at 0.5 mg, light range at 0.5–1 mg, common reference range at 1–2 mg, strong intensity at 2–4 mg, and heavy/adverse territory at 4–5+ mg, with an onset of 20–45 min, peak window of 1.5–3 h, and total duration of 6–10 h (8–18 h residual sedation). 1 tablet = 1 mg sits at the light-to-common threshold; compared to Etizolam, Bromazolam is heavier on physical muscle relaxation and sedation and lasts 2–3 hours longer, while remaining significantly more forgiving per mg than Flualprazolam or Clonazolam. Critical contraindications include Opioids (O-DSMT, tramadol, morphine, oxycodone, fentanyl), Alcohol, GHB/GBL, and Barbiturates.

Compare within “Benzodiazepines and thienodiazepines” — if you are looking for a related compound

Side-by-side comparison of chemical parameters, positional isomers, and available portion sizes in this structural class:

Compound Molecular formula Molar mass CAS number Portions & starting price Sheet
Bromazolam Current listing
C17H13BrN4 353.2 g/mol 71368-80-4 0.001 g – 0.2 g · 4.00 GBP Current listing
Clonazolam Same class (Benzodiazepines and thienodiazepines)
C17H12ClN5O2 353.8 g/mol 33887-02-4 0.001 g – 0.1 g · 4.00 GBP View sheet →
Etizolam Same class (Benzodiazepines and thienodiazepines)
C17H15ClN4S 342.8 g/mol 40054-69-1 0.001 g – 0.1 g · 4.00 GBP View sheet →
Flualprazolam Same class (Benzodiazepines and thienodiazepines)
C17H12ClFN4 326.8 g/mol 28910-91-0 0.001 g – 0.1 g · 4.00 GBP View sheet →

Comments

No comments yet.

Rate this product

You looked at these listings

You may also like